PCOS and Fertility: What Every Woman With PCOD Needs to Know Before Starting IVF

What Is PCOS? The Hormonal Disruption Behind the Diagnosis

PCOS (Polycystic Ovary Syndrome) — called PCOD (Polycystic Ovarian Disease) in common Indian usage — is not simply a condition of cysts on the ovaries. It is a complex endocrine disorder characterised by three core disturbances that interact with each other in a self-reinforcing cycle.

The Rotterdam 2023 Criteria — the current international diagnostic standard — require that at least 2 of the first 3 features be present. Insulin resistance, while extremely common in PCOS, is not required for diagnosis but has significant implications for IVF protocol design.

To understand the full clinical picture and available treatment pathways before proceeding to IVF, see our dedicated page: PCOS / PCOD Treatment at Wellspring IVF.

How PCOS Affects Your Fertility: The Hormonal Cascade

PCOS affects fertility primarily through ovulatory dysfunction — the absence or irregularity of ovulation — which is the direct cause of conception difficulty in most PCOS patients. Understanding the mechanism matters because it also explains why the IVF approach must be adjusted.

The LH/FSH Imbalance

In a normal cycle, FSH (follicle-stimulating hormone) rises just enough to recruit a single dominant follicle to maturity, which then ovulates. In PCOS, LH is chronically elevated relative to FSH. This elevated LH stimulates androgen production in the ovarian theca cells, which arrests follicle development at the small antral stage. The result: dozens of small follicles but none that mature to ovulation.

Insulin Resistance and the Androgen Loop

In the 50–70% of PCOS patients with insulin resistance, elevated insulin directly stimulates ovarian androgen production and reduces Sex Hormone Binding Globulin (SHBG), increasing free testosterone. This creates a self-sustaining loop: high insulin → high androgens → arrested follicle development → anovulation → persistent hormonal dysregulation. Metformin — frequently used in pre-IVF PCOS preparation — works partly by breaking this loop.

AMH and Antral Follicle Count in PCOS

AMH is typically significantly elevated in PCOS — often in the range of 4–10 ng/mL or higher — reflecting the large pool of arrested antral follicles. This is the opposite of the low AMH / poor ovarian reserve scenario. High AMH in PCOS is not a fertility advantage in itself — it signals a large pool of follicles available but also a heightened risk of over-response during IVF stimulation.

PCOS Diagnosis: Which Tests You Actually Need Before IVF

A proper pre-IVF diagnostic workup in a PCOS patient is not just confirming the PCOS diagnosis — it is mapping the metabolic and hormonal landscape that will directly inform the IVF protocol. The tests I routinely request at Wellspring before designing a PCOS IVF plan include:

• Day 2 / Day 3 hormone panel: FSH, LH, E2, AMH, Total Testosterone, DHEAS, Prolactin, TSH
• Transvaginal ultrasound: Antral follicle count (AFC) per ovary — critical for stimulation dose calibration
• Fasting glucose and fasting insulin (to calculate HOMA-IR and identify insulin resistance severity)
• HbA1c — particularly if BMI is elevated or glucose tolerance is borderline
• Lipid profile — metabolic syndrome co-exists with PCOS in a significant proportion of patients
• Semen analysis for male partner — male factor co-exists in 30–40% of PCOS-associated infertility cases
• Uterine cavity assessment via hysterosonography or hysteroscopy if indicated (endometrial polyps are more common in PCOS due to chronic anovulation and endometrial exposure to unopposed estrogen)

If any uterine cavity anomaly is detected, hysteroscopy may be recommended before embryo transfer to optimise the implantation environment.

Is IVF the Right First Step for PCOS? An Honest Assessment

No — and at Wellspring, I am explicit about this with every PCOS patient. IVF is not the first step for most PCOS patients. It is a step taken after simpler interventions have either failed or been clinically ruled out. The decision depends on the complete clinical picture: duration of infertility, age, male factor status, tubal patency, and response to prior treatment.

For a complete overview of IVF treatment at Wellspring, including protocol structure, success rates, and costs, see: IVF Treatment Ahmedabad — Wellspring IVF.

The Biggest Risk in PCOS IVF: Ovarian Hyperstimulation Syndrome (OHSS)

OHSS is the most clinically significant risk specific to PCOS patients undergoing IVF — and the primary reason that a PCOS IVF protocol must differ from a standard protocol. Every PCOS patient must understand OHSS before starting treatment, not to be alarmed, but to make informed decisions.

What Is OHSS?

Ovarian Hyperstimulation Syndrome is an exaggerated response to gonadotrophin stimulation in which the ovaries become enlarged and fluid leaks from blood vessels into the abdominal cavity. In its severe form, OHSS can cause significant abdominal distension, fluid accumulation, blood clotting, and in rare cases, serious systemic complications. The majority of cases are mild to moderate and resolve with monitoring and supportive management. Severe OHSS, when it occurs, requires hospitalisation.

Why PCOS Patients Are at Higher Risk

PCOS patients have a large pool of antral follicles (high AFC) and typically elevated AMH. During IVF stimulation, gonadotrophins recruit far more follicles than in a normal patient — meaning a far larger estrogen surge and far more ovarian activity than anticipated. The risk of OHSS in unmodified IVF cycles is significantly higher in PCOS, particularly when the antagonist protocol is not used and when fresh embryo transfer is attempted in the same cycle as stimulation.

How Dr. Shah Minimises OHSS Risk at Wellspring

Managing OHSS risk in a PCOS IVF cycle is not about avoiding stimulation — it is about designing the stimulation protocol precisely, monitoring intensively, and having a pre-planned response strategy. The key interventions I use at Wellspring for PCOS patients:

• Antagonist Protocol: GnRH antagonist cycles allow us to trigger ovulation with a GnRH agonist trigger instead of hCG. This is the single most effective intervention to prevent severe OHSS — the agonist trigger produces a brief LH surge that recruits eggs but carries a dramatically lower OHSS risk than an hCG trigger.
• Low starting dose: Gonadotrophin starting doses in PCOS are calibrated conservatively — typically 100–150 IU rather than the 225 IU that might be used in a poor responder. This is adjusted based on AFC, AMH, and daily stimulation response.
• Cabergoline: A dopamine agonist that is routinely prescribed in high-risk PCOS cycles to reduce vascular permeability and lower OHSS severity if it develops.
• Freeze-all strategy: In cycles where the response is strong and OHSS risk is elevated, all embryos are cryopreserved and transferred in a subsequent Frozen Embryo Transfer (FET) cycle — when the ovaries have fully recovered and the uterine environment is optimal.
• Intensive monitoring: Daily or alternate-day ultrasound and estradiol monitoring during stimulation allows early identification of over-response and real-time dose adjustment.

The Freeze-All Strategy: Why Most PCOS IVF Cycles End in FET

In the majority of PCOS IVF cycles at Wellspring, we do not perform a fresh embryo transfer in the same stimulation cycle. All embryos are cryopreserved (frozen), and the transfer is performed in a separate, subsequent Frozen Embryo Transfer (FET) cycle. This is the freeze-all strategy, and for PCOS patients specifically, it has two major evidence-based benefits:

• OHSS prevention: Fresh transfer in a hyperstimulated PCOS cycle dramatically increases OHSS severity risk. Pregnancy itself amplifies OHSS through hCG production. Freeze-all eliminates this risk entirely — the transfer happens when the ovaries have completely recovered.
• Better implantation: Controlled FET cycles allow precise endometrial preparation under monitored estrogen and progesterone — often producing better endometrial receptivity than a fresh cycle environment. Multiple randomised trials (including the Shi et al. 2018 NEJM trial) have shown higher live birth rates in FET vs. fresh transfers in PCOS patients.

For a complete explanation of the FET process, endometrial preparation protocol, and what to expect: Frozen Embryo Transfer at Wellspring IVF.

PCOS and Embryo Quality: What the Evidence Actually Says

A common concern among PCOS patients is whether the condition affects egg or embryo quality. The
answer is nuanced and important to understand correctly:

Lifestyle Changes That Improve PCOS IVF Outcomes

This section is not about generic wellness advice. These are specific, evidence-supported lifestyle interventions that have documented effects on PCOS fertility outcomes:

Weight Management and BMI Optimisation

A 5–7% reduction in body weight in overweight PCOS patients (BMI >27) has been shown to restore ovulation in 55–60% of cases and improve IVF response predictability. This does not require reaching a ‘normal’ BMI — even modest weight reduction has a measurable hormonal impact through reduced insulin and androgen levels.

Low Glycaemic Index Diet

A low-GI diet reduces insulin spikes, which in turn reduces ovarian androgen production. Practically this means: replacing refined carbohydrates (white rice, white bread, sugar) with slow-release alternatives (brown rice, oats, legumes), prioritising protein and healthy fats, and minimising ultra-processed food. This is not a fad diet — it is a targeted insulin-sensitising dietary intervention.

Targeted Supplementation

• Inositol (Myo-inositol and D-chiro-inositol combination): Improves insulin sensitivity, reduces LH/FSH ratio, and has a documented positive effect on oocyte quality in PCOS. Available OTC and generally well-tolerated.
• Vitamin D: Deficiency is present in 67–85% of Indian PCOS patients. Vitamin D plays a direct role in folliculogenesis and insulin signalling. Always check levels before supplementing.
• Omega-3 fatty acids: Anti-inflammatory; may reduce androgen levels modestly in PCOS.
• Folic acid / Methylfolate: Standard pre-conception supplementation, 400–800 mcg daily, started 3 months before IVF.

Note: Always discuss any supplement protocol with Dr. Shah before starting. Dosing and combinations matter, and some supplements interact with IVF medications.

Exercise: Type and Timing Matter

Moderate aerobic exercise (30 minutes, 5 days per week) improves insulin sensitivity and reduces androgen levels in PCOS. High-intensity exercise during the IVF stimulation phase (from Day 2 of stimulation until after the pregnancy test) should be avoided due to the risk of ovarian torsion in an over-responding cycle. Walk-based and low-impact exercise is appropriate during the stimulation phase.